Skip to main content
OpenTrials

Clinical trial condition

Meningeal Neoplasms

Explore clinical trials studying Meningeal Neoplasms. Study availability and eligibility vary by location and protocol.

271 public trials 86 recruiting studies
Refine in advanced search Browse all conditions

Meningeal Neoplasms trial results

Completed

Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors

NCT00369785

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +37 more
Locations
  • Associates in Womens Health, PA - North Review Wichita, Kansas, United States
  • Cancer Center of Kansas, PA - Medical Arts Tower Wichita, Kansas, United States
  • Cancer Center of Kansas, PA - Wichita Wichita, Kansas, United States
  • CCOP - Wichita Wichita, Kansas, United States
View all 16 locations
View Trial Details
Completed

Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor

NCT00070161

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +31 more
Locations
  • CCOP - Western Regional, Arizona Phoenix, Arizona, United States
  • Regional Radiation Oncology Center at Rome Rome, Georgia, United States
  • Comprehensive Cancer Center at Wake Forest University Winston-Salem, North Carolina, United States
  • CCOP - Upstate Carolina Spartanburg, South Carolina, United States
View Trial Details
Completed

Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy

NCT01346267

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +27 more
Locations
  • Miller Children's Hospital Long Beach, California, United States
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Connecticut Children's Medical Center Hartford, Connecticut, United States
  • A I duPont Hospital for Children Wilmington, Delaware, United States
View all 25 locations
View Trial Details
Completed

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

NCT01125046

Conditions
Acoustic Schwannoma, Adult Anaplastic Meningioma, Adult Ependymoma, +51 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • University of Virginia Charlottesville, Virginia, United States
View Trial Details
Completed

Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung Cancer

NCT02228369

Conditions
Brain Diseases, Brain Neoplasms, Bronchial Neoplasms, +16 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Santa Monica, California, United States
  • Research Site Camperdown, Australia
  • Research Site Heidelberg, Australia
View Trial Details

Related conditions